-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WWQBfPtUEjQgVjT5dZm3YSMfmOy1mr68kz3SFECO7UtwW5baQkdA6Ye7eV9F+Znk zDi36VvEPwzxorxlnglJIw== 0000950136-07-004130.txt : 20070613 0000950136-07-004130.hdr.sgml : 20070613 20070613060248 ACCESSION NUMBER: 0000950136-07-004130 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20070613 DATE AS OF CHANGE: 20070613 GROUP MEMBERS: PERSHING SQUARE GP, LLC GROUP MEMBERS: PS MANAGEMENT GP, LLC GROUP MEMBERS: WILLIAM A. ACKMAN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CERIDIAN CORP /DE/ CENTRAL INDEX KEY: 0001124887 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 411981625 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-61527 FILM NUMBER: 07916285 BUSINESS ADDRESS: STREET 1: 3311 E OLD SHAKOPEE RD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 BUSINESS PHONE: 9528538100 MAIL ADDRESS: STREET 1: 3311 EAST OLD SHAKOPEE RD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 FORMER COMPANY: FORMER CONFORMED NAME: NEW CERIDIAN CORP DATE OF NAME CHANGE: 20000927 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Pershing Square Capital Management, L.P. CENTRAL INDEX KEY: 0001336528 IRS NUMBER: 383694136 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 29TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-813-3700 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 29TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 SC 13D/A 1 file1.htm FORM SC 13D/A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 7)*

Ceridian Corporation

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

156779100

(CUSIP Number)

Roy J. Katzovicz
Pershing Square Capital Management, L.P.
888 Seventh Avenue, 29th Floor
New York, NY 10019
212-813-3700

with a copy to:

Alan J. Sinsheimer
Sullivan & Cromwell LLP
125 Broad Street
New York, NY 10004-2498
212-558-4000

and

Janet T. Geldzahler
Sullivan & Cromwell LLP
1701 Pennsylvania Avenue, N.W.
Washington, D.C. 20006-5805
202-956-7500

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

June 12, 2007

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: [ ]

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss. 240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be ‘‘filed’’ for the purpose of Section 18 of the Securities Exchange Act of 1934 (‘‘Act’’) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




CUSIP No. 156779100


 
1 Name of Reporting Person
I.R.S. Identification Nos. of Above Person (entities only)
    
Pershing Square Capital Management, L.P.
2 Check the Appropriate Box if a Member of a Group (See instructions)     
(a) [    ]
(b) [X]
3 SEC Use Only
4 Source of Funds (See Instructions)
OO
5 Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
[    ]
6 Citizenship or Place of Organization
Delaware

    
    
Number of
Shares
Beneficially
Owned by Each
Reporting
Person With
7 Sole Voting Power
-0-
8 Shared Voting Power
21,432,734
9 Sole Dispositive Power
-0-
10 Shared Dispositive Power
21,432,734

 
11 Aggregate Amount Beneficially Owned by Each Reporting Person
21,432,734
12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
[    ]
13 Percent of Class Represented by Amount in Row (11)
14.9%1
14 Type of Reporting Person (See Instructions)
IA
1 Calculated based on 143,565,452 shares of the common stock, par value $0.01, of Ceridian Corporation outstanding as of May 24, 2007, as represented by Ceridian Corporation in Exhibit 2.1 to its Form 8-K dated May 31, 2007.



CUSIP No. 156779100


 
1 Name of Reporting Person
I.R.S. Identification Nos. of Above Person (entities only)
    
PS Management GP, LLC
2 Check the Appropriate Box if a Member of a Group (See instructions)     
(a) [    ]
(b) [X]
3 SEC Use Only
4 Source of Funds (See Instructions)
OO
5 Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
[    ]
6 Citizenship or Place of Organization
Delaware

    
    
Number of
Shares
Beneficially
Owned by Each
Reporting
Person With
7 Sole Voting Power
-0-
8 Shared Voting Power
21,432,734
9 Sole Dispositive Power
-0-
10 Shared Dispositive Power
21,432,734

 
11 Aggregate Amount Beneficially Owned by Each Reporting Person
21,432,734
12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
[    ]
13 Percent of Class Represented by Amount in Row (11)
14.9%2
14 Type of Reporting Person (See Instructions)
OO
2 Calculated based on 143,565,452 shares of the common stock, par value $0.01, of Ceridian Corporation outstanding as of May 24, 2007, as represented by Ceridian Corporation in Exhibit 2.1 to its Form 8-K dated May 31, 2007.



CUSIP No. 156779100


 
1 Name of Reporting Person
I.R.S. Identification Nos. of Above Person (entities only)
    
Pershing Square GP, LLC
2 Check the Appropriate Box if a Member of a Group (See instructions)     
(a) [    ]
(b) [X]
3 SEC Use Only
4 Source of Funds (See Instructions)
OO
5 Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
[    ]
6 Citizenship or Place of Organization
Delaware

    
    
Number of
Shares
Beneficially
Owned by Each
Reporting
Person With
7 Sole Voting Power
-0-
8 Shared Voting Power
9,354,807
9 Sole Dispositive Power
-0-
10 Shared Dispositive Power
9,354,807

 
11 Aggregate Amount Beneficially Owned by Each Reporting Person
9,354,807
12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
[    ]
13 Percent of Class Represented by Amount in Row (11)
6.5%3
14 Type of Reporting Person (See Instructions)
IA
3 Calculated based on 143,565,452 shares of the common stock, par value $0.01, of Ceridian Corporation outstanding as of May 24, 2007, as represented by Ceridian Corporation in Exhibit 2.1 to its Form 8-K dated May 31, 2007.



CUSIP No. 156779100


1 Name of Reporting Person
I.R.S. Identification Nos. of Above Person (entities only)
    
William A. Ackman
2 Check the Appropriate Box if a Member of a Group (See instructions)     
(a) [    ]
(b) [X]
3 SEC Use Only
4 Source of Funds (See Instructions)
OO
5 Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
[    ]
6 Citizenship or Place of Organization
United States

    
    
Number of
Shares
Beneficially
Owned by Each
Reporting
Person With
7 Sole Voting Power
-0-
8 Shared Voting Power
21,432,734
9 Sole Dispositive Power
-0-
10 Shared Dispositive Power
21,432,734

 
11 Aggregate Amount Beneficially Owned by Each Reporting Person
21,432,734
12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
[    ]
13 Percent of Class Represented by Amount in Row (11)
14.9%4
14 Type of Reporting Person (See Instructions)
IN
4 Calculated based on 143,565,452 shares of the common stock, par value $0.01, of Ceridian Corporation outstanding as of May 24, 2007, as represented by Ceridian Corporation in Exhibit 2.1 to its Form 8-K dated May 31, 2007.



Item 1.  Security and Issuer.

This amendment No. 7 (this ‘‘Amendment’’) amends and supplements the statement on Schedule 13D (the ‘‘Original Schedule 13D’’), filed on January 18, 2007 by Pershing Square Capital Management, L.P., a Delaware limited partnership, PS Management GP, LLC, a Delaware limited liability company, Pershing Square GP, LLC, a Delaware limited liability company, and William A. Ackman, a citizen of the United States of America (collectively, the ‘‘Reporting Persons’’), the amendment No. 1 to the Original Schedule 13D, filed on January 23, 2007 by the Reporting Persons, the amendment No. 2 to the Original Schedule 13D, filed on February 6, 2007 by the Reporting Persons, the amendment No. 3 to the Original Schedule 13D, filed on February 28, 2007 by the Reporting Persons, the amendment No. 4 to the Original Schedule 13D, filed on March 1, 2007 by the Repo rting Persons, the amendment No. 5 to the Original Schedule 13D, filed on May 2, 2007 by the Reporting Persons, and the amendment No. 6 to the Original Schedule 13D, filed on May 14, 2007 by the Reporting Persons, relating to the common stock, par value $0.01 per share (the ‘‘Common Stock’’), of Ceridian Corporation, a Delaware corporation (the ‘‘Issuer’’). The address of the principal executive offices of the Issuer is 3311 East Old Shakopee Road, Minneapolis, Minnesota 55425. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Original Schedule 13D.

Item 4.  Purpose of Transaction.

Item 4 is hereby supplemented as follows:

On June 12, representatives of the Reporting Persons circulated an open letter to the Issuer’s stockholders, a copy of which is attached as Exhibit 99.1 hereto. As described in the letter, the Reporting Persons are seeking value-maximizing alternatives in response to the $36 per share price contemplated by the Agreement and Plan of Merger, dated as of May 30, 2007, entered into by the Issuer. Such alternatives could include a sale of the entire company at a price greater than $36 per share, a sale or separation of one or both of the company’s main operating units and/or a recapitalization, dividend or self-tender transaction where significant value could be returned to stockholders, whether in combination with a broader transaction or otherwise. Investment funds managed by the Reporting Persons may participate in sponsoring one or more of these alternative transactions, which could involve additional strategic partners or financial sponsors. The re can be no assurance that any such transaction will be proposed or, if proposed, accepted or consummated.

Item 5.  Interest in Securities of the Issuer.

Item 5 is hereby amended and supplemented as follows:

(a) Based on Exhibit 2.1 to the Issuer’s Form 8-K dated May 31, 2007, there were 143,565,452 shares of the Common Stock outstanding as of May 24, 2007. Based on the foregoing, the 21,432,734 shares of the Common Stock beneficially owned by the Reporting Persons represent approximately 14.9% of the shares of the Common Stock issued and outstanding.

(c) See trading data attached hereto as Exhibit 99.2.  Exhibit 99.2 is incorporated by reference into this Item 5(c) as if restated in full.

Except as set forth in Exhibit 99.2 attached hereto, in the period since May 15, 2007, no other transactions in shares of the Common Stock were effected by any Reporting Person.

Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Under the terms of the engagement with Lazard Frères & Co. LLC (‘‘Lazard’’), referred to in the letter to the Issuer’s stockholders, Lazard will, in addition to its retention fee, receive a fee of $1,500,000 if the shares of Common Stock held by the Reporting Persons or the funds they advise are sold, transferred, exchanged, redeemed or converted in a sale of the Issuer for a per share amount equal to or greater than $38.50, and Lazard will receive 10% of the proceeds in excess of $38.50 (but less than or equal to $41.00) per share received by such parties, and 15% of the proceeds in excess of $41.00 per share received by such parties.




Item 7.  Material to be Filed as Exhibits.

Item 7 is hereby supplemented by adding the following exhibits:

Exhibit 99.1  Open Letter, dated June 12, 2007, from Pershing Square Capital Management, L.P. to Ceridian Corporation Stockholders.
Exhibit 99.2  Trading data of the transactions in the Common Stock that were effected in the period since May 15, 2007.

.




SIGNATURES

After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Dated: June 12, 2007

PERSHING SQUARE CAPITAL MANAGEMENT, L.P.

  By: PS Management GP, LLC,
its General Partner

  By: /s/ William A. Ackman
    William A. Ackman
Managing Member

    

PS MANAGEMENT GP, LLC

  By: /s/ William A. Ackman
    William A. Ackman
Managing Member
PERSHING SQUARE GP, LLC

  By: /s/ William A. Ackman
    William A. Ackman
Managing Member

  /s/ William A. Ackman
  WILLIAM A. ACKMAN



EXHIBIT INDEX


Exhibit Description
99 .1. Letter, dated June 12, 2007, from Pershing Square Capital Management, L.P. to Ceridian Corporation Stockholders.
99 .2. Trading data of the transactions in the Common Stock that were effected in the period since May 15, 2007.



EX-99.1 2 file2.htm LETTER TO CERIDIAN SHAREHOLDERS


June 12, 2007

Open Letter to Fellow Ceridian Corporation Stockholders

Dear Fellow Ceridian Owners:

As you know, the incumbent board of Ceridian Corporation has embarked on a path to sell the company to a consortium of buyers at $36 per share.  We do not support a sale of the company at this low price.  It appears to us that the current deal is an ill-suited response to our proxy contest, and is suboptimal for Ceridian stockholders.

We have retained Lazard Frères & Co. LLC as our financial advisor and are working with Sullivan & Cromwell LLP as our legal advisor. We intend to pursue one or more value-maximizing alternatives.  Since the announcement of the current deal, we have received expressions of interests from both strategic buyers and financial sponsors who are interested in pursuing a variety of possible transactions.

In our view, the value-maximizing course of action is the pursuit of one or a combination of the following alternatives:  (1) a sale of the entire company at a higher price, (2) a sale or separation of one or both of the company’s main operating units, and/or (3) a recapitalization, dividend or self-tender transaction where significant value can be returned to stockholders, whether in combination with a broader transaction or otherwise.

Investment funds managed by Pershing Square Capital Management, L.P. may participate in sponsoring one or more of these alternative transactions, which could involve additional strategic partners or financial sponsors. We expect, therefore, to approach the company to seek information relevant to our formulation of a more definitive proposal.

Should Ceridian have obtained standstill agreements from any potential bidders, we believe that the incumbent board’s fiduciary duties require Ceridian to waive those standstills and cooperate to enable this process to achieve the highest value reasonably obtainable for all Ceridian stockholders.  We ask that you send this same message to the company.

 

PERSHING SQUARE CAPITAL MANAGEMENT, L.P.

 

Sincerely,

 


/s/ William A. Ackman






EX-99.2 3 file3.htm TRADING DATA

Exhibit 99.2

Pershing Square L.P.


Tran Code Security Trade Date Settle Date Quantity Unit Cost Trade Amount
BUY CERIDIAN CORPORATION June 4, 2007 June 7, 2007 37,658 $ 35.44 $ 1,334,562
BUY CERIDIAN CORPORATION June 4, 2007 June 7, 2007 42,229 $ 35.42 $ 1,495,722
BUY CERIDIAN CORPORATION June 5, 2007 June 8, 2007 139,796 $ 35.31 $ 4,936,085
BUY CERIDIAN CORPORATION June 5, 2007 June 8, 2007 19,208 $ 35.31 $ 678,323

Pershing Square International Ltd.


Tran Code Security Trade Date Settle Date Quantity Unit Cost Trade Amount
BUY CERIDIAN CORPORATION June 4, 2007 June 7, 2007 202,507 $ 35.44 $ 7,176,646
BUY CERIDIAN CORPORATION June 4, 2007 June 7, 2007 227,086 $ 35.42 $ 8,043,227
BUY CERIDIAN CORPORATION June 5, 2007 June 8, 2007 183,154 $ 35.31 $ 6,467,021
BUY CERIDIAN CORPORATION June 5, 2007 June 8, 2007 25,166 $ 35.31 $ 888,727

Pershing Square II, L.P.


Tran Code Security Trade Date Settle Date Quantity Unit Cost Trade Amount
BUY CERIDIAN CORPORATION June 4, 2007 June 7, 2007 9,835 $ 35.44 $ 348,543
BUY CERIDIAN CORPORATION June 4, 2007 June 7, 2007 11,029 $ 35.42 $ 390,639
BUY CERIDIAN CORPORATION June 5, 2007 June 8, 2007 2,050 $ 35.31 $ 72,384
BUY CERIDIAN CORPORATION June 5, 2007 June 8, 2007 282 $ 35.31 $ 9,959



GRAPHIC 4 spacer.gif begin 644 spacer.gif K1TE&.#EA`0`!`(```````````"'Y!`$`````+``````!``$```("1`$`.S\_ ` end
-----END PRIVACY-ENHANCED MESSAGE-----